Advertisement
OtherArticle

Short Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Over-expression, Promotes Atherosclerosis Inflammation Resolution Mice

Jaume Amengual, Yoscar Ogando, Cyrus Nikain, Alexandra Quezada, Kun Qian, Tomas Vaisar and Edward A Fisher
Molecular Pharmacology December 31, 2020, MOLPHARM-AR-2020-000108; DOI: https://doi.org/10.1124/molpharm.120.000108
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
OtherArticle

ACAT Inhibition and APOA1 promote atherosclerosis resolution

Jaume Amengual, Yoscar Ogando, Cyrus Nikain, Alexandra Quezada, Kun Qian, Tomas Vaisar and Edward A Fisher
Molecular Pharmacology December 31, 2020, MOLPHARM-AR-2020-000108; DOI: https://doi.org/10.1124/molpharm.120.000108
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section